Applying the health belief model to the rational use of drugs for hemodialysis patients: A randomized controlled trial

Basit Öğe Kaydı
dc.authoridCENGİZ, ZELİHA/0000-0002-3819-1717
dc.authoridUCUZAL, MERAL/0000-0003-3930-3490
dc.authorwosidCENGİZ, ZELİHA/ABI-4480-2020
dc.authorwosidUCUZAL, MERAL/B-1556-2018
dc.contributor.authorCengiz, Zeliha
dc.contributor.authorOzkan, Meral
dc.date.accessioned2024-08-04T20:50:23Z
dc.date.available2024-08-04T20:50:23Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground: Non-rational use of drugs is a common problem among people with chronic disease. The Health Belief Model (HBM) can develop beliefs and behaviors related to rational drug use. Objectives: To investigate the effect of HBM-based training on the rational use of drugs in hemodialysis patients. Methods: This randomized controlled trial was conducted in 132 people receiving hemodialysis treatment. The data were collected using a Demographic Survey and the Rational Use of Drugs Scale (RUDS). Patients in the study groups were provided with HBM-based rational use of drugs training. The first training session took an average of 30-35 min for each patient, and the second (summary) took an average of 15-20 min Results: The mean RUDS pretest score was 60.29 +/- 10.17 in the intervention group and 62.85 +/- 9.94 in the control group. The mean RUDS posttest scores were 78.80 +/- 8.16 in the intervention group and 63.48 +/- 9.77 in the control group. The difference between the pretest scores in these groups was not statistically significant (p > 0.05), whereas the difference between the posttest scores was found to be significant (p < 0.001). Conclusion: It was observed that training based on the HBM increased the RUD scores. Thus, HBM may be recommended for use as a guide for rational drug use training, especially for patients undergoing hemo-dialysis. Practice implications: The HBM can be an effective and cost-efficient strategy for standardized rational drug use training and supporting hemodialysis patients. (c) 2021 Elsevier B.V. All rights reserved.en_US
dc.identifier.doi10.1016/j.pec.2021.06.024
dc.identifier.endpage685en_US
dc.identifier.issn0738-3991
dc.identifier.issn1873-5134
dc.identifier.issue3en_US
dc.identifier.pmid34217550en_US
dc.identifier.scopus2-s2.0-85109024127en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage679en_US
dc.identifier.urihttps://doi.org/10.1016/j.pec.2021.06.024
dc.identifier.urihttps://hdl.handle.net/11616/100018
dc.identifier.volume105en_US
dc.identifier.wosWOS:000820505900020en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Ireland Ltden_US
dc.relation.ispartofPatient Education and Counselingen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHealth belief modelen_US
dc.subjectHealth educationen_US
dc.subjectHemodialysisen_US
dc.subjectRational use of drugsen_US
dc.titleApplying the health belief model to the rational use of drugs for hemodialysis patients: A randomized controlled trialen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu